Related Experiment Video

Updated: Sep 22, 2025

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

5.8K

Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment

Liyun Zhu1,2, Danni Meng1,2, Xu Wang3

  • 1Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), School of Medicine, Shanghai University, Nantong 226011, China.

ACS Applied Bio Materials
|May 26, 2022
PubMed

Insights

Ferroptosis, an iron-dependent cell death, offers a novel approach to combatting drug-resistant cancers. Ferroptosis-driven nanotherapeutics accumulate lethal reactive oxygen species (ROS) and lipid peroxidation (LPO) to eradicate aggressive tumors.

Area of Science:

  • Oncology
  • Biochemistry
  • Materials Science

Background:

  • Ferroptosis is programmed cell death driven by iron-dependent lipid reactive oxygen species (ROS) accumulation.
  • Cancer cells exploit lipid metabolism and GPX4 to resist ferroptosis, contributing to oncogenesis and drug resistance.
  • Ferroptosis-inducing nanotherapeutics show promise in eradicating aggressive, metastatic, and drug-resistant tumors.

Purpose of the Study:

  • To review current trends in ferroptosis-driven nanotherapeutics for overcoming tumor drug resistance.
  • To explore the intersection of cancer biology, materials science, and chemistry in developing these therapies.
  • To highlight challenges and future perspectives for clinical translation.

Main Methods:

  • Review of literature on ferroptosis induction strategies (Fenton reaction, GPX4 inhibition, LPO regulation).
  • Analysis of nanotherapeutic applications targeting lipid metabolism and ROS accumulation in cancer.
  • Discussion of multidisciplinary approaches combining cancer biology, materials science, and chemistry.

Main Results:

  • Ferroptosis-driven nanotherapeutics effectively induce ROS and lipid peroxidation (LPO) to lethal levels in the tumor microenvironment (TME).
  • These strategies demonstrate superior efficacy against aggressive, metastatic, and drug-resistant cancers compared to traditional therapies.
  • Key therapeutic strategies include Fenton reaction, GPX4 inhibition, and exogenous LPO regulation.

Conclusions:

  • Ferroptosis-driven nanotherapeutics represent a promising strategy to reverse tumor drug resistance.
  • Multidisciplinary research integrating cancer biology, materials science, and chemistry is crucial for advancing this field.
  • Addressing current challenges is essential for the feasible translational studies and clinical application of ferroptosis-based cancer treatments.
Keywords:
anticancer treatmentdrug resistanceferroptosisnanotherapeuticstumor microenvironment

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

506
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K